NCT06200961 Trans-nasal Endoscopy for Bariatric Patients
| NCT ID | NCT06200961 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Christopher C. Thompson, MD, MSc |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2026-04-20 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study plans to learn if the EvoEndo Endoscopy system can be used to evaluate, provide and follow up care for upper gastrointestinal tract diseases in the bariatric population. The smallest current scope available for such a technique is an adult transnasal endoscope with a larger diameter, a pulmonary bronchoscope or Ear Nose and Throat (ENT) laryngoscope. This study is evaluating a newly Food and Drug Administration (FDA) cleared ultra-slim, single-use, endoscope specifically designed for transnasal endoscopy to evaluate its use in adult upper tract gastrointestinal diseases. If such a technique is successful it could improve the safety, cost, and access of endoscopic care for patients in need of an endoscopic evaluation for a bariatric medical condition.
Eligibility Criteria
Inclusion Criteria: 1. Patient 18 years of age and less than 90 years of age with clinically referred for esophagoscopy, gastroscopy, or esophagogastroduodenoscopy (EGD) 2. Cared for in metabolic and bariatric clinic Exclusion Criteria: 1. Patient \<18 years of age 2. Medically contraindicated to perform EGD or TNE 3. Inability to provide informed consent
Contact & Investigator
Christopher C. Thompson, MD, MSc
PRINCIPAL INVESTIGATOR
Brigham and Womens Hospital
Frequently Asked Questions
Who can join the NCT06200961 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06200961 currently recruiting?
Yes, NCT06200961 is actively recruiting participants. Contact the research team at mryan@bwh.harvard.edu for enrollment information.
Where is the NCT06200961 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT06200961 clinical trial?
NCT06200961 is sponsored by Christopher C. Thompson, MD, MSc. The principal investigator is Christopher C. Thompson, MD, MSc at Brigham and Womens Hospital. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.